Booster Therapeutics has announced its inception, backed by a $15m investment, to develop a new class of proteasome activator ...
The proteasome is a large protein complex in the cytoplasm of eukaryotic and archaeal cells responsible for proteolysis of proteins that have one or more poly-ubiquitin post-translational ...
The team concentrated on the proteasome, which functions as a sort of recycling bin for the cell. Through the operations of ...